⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for first line treatment gastroesophageal junction (gej)

Every month we try and update this database with for first line treatment gastroesophageal junction (gej) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) AdenocarcinomaNCT01697072
Gastric Cancer
Rilotumumab
Placebo
Epirubicin
Cisplatin
Capecitabine
18 Years - 99 YearsAmgen
First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) AdenocarcinomaNCT01697072
Gastric Cancer
Rilotumumab
Placebo
Epirubicin
Cisplatin
Capecitabine
18 Years - 99 YearsAmgen
First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) AdenocarcinomaNCT01697072
Gastric Cancer
Rilotumumab
Placebo
Epirubicin
Cisplatin
Capecitabine
18 Years - 99 YearsAmgen
A Phase 3 Study of Rilotumumab (AMG 102) With Cisplatin and Capecitabine (CX) as First-line Therapy in Gastric CancerNCT02137343
Gastric Cancer
Rilotumumab
Placebo
Cisplatin
Capecitabine
20 Years - 100 YearsAmgen
A Phase 3 Study of Rilotumumab (AMG 102) With Cisplatin and Capecitabine (CX) as First-line Therapy in Gastric CancerNCT02137343
Gastric Cancer
Rilotumumab
Placebo
Cisplatin
Capecitabine
20 Years - 100 YearsAmgen
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: